Target Entity: Splendid Hospitals Private Limited (Kompally)

Type of Deal: Strategic minority acquisition through primary equity infusion

Stake/Capacity: KIMS will acquire up to 22% of equity shares of Rs. 10 each

Deal Value: Aggregate consideration of up to ₹40.00 Crore (Rupees Forty Crore only)

Funding Source: Cash consideration

Financial Impact:

  • Target company financials:
  • FY 2025-26 Turnover: ₹1.39 Crore
  • FY 2025-26 PAT: -₹8.92 Crore (loss)
  • Networth: ₹38.69 Crore
  • Historical turnover: FY24 (₹0.00 Crore), FY25 (₹0.30 Crore), FY26 (₹1.39 Crore)
  • The hospital has expansion potential to over 225+ beds
  • Equipped with latest medical infrastructure, diagnostic equipment, and multiple operation theatres

Timeline: Acquisition to be completed on or before 31st March, 2027

Strategic Rationale:

  • KIMS is currently the O&M (Operations & Management) Partner of the target entity
  • The acquisition represents a strategic investment to strengthen this partnership
  • The hospital has significant potential due to its location and growing demand for hospital services in Kompally, Telangana

Approval Status: Board-approved on 06th October, 2026

Regulatory Aspects:

  • Does not fall within the definition of Related Party Transaction
  • No governmental or regulatory approvals required
  • Valuation conducted by BDO Valuation Advisory LLP, dated 05th October, 2026

Company Background:

  • Splendid Hospitals Private Limited incorporated on 20-09-2022
  • Operates exclusively in Kompally, Telangana, India

Reference Regulation: SEBI Regulation 30 of Listing Obligations and Disclosure Requirements Regulations, 2015, read with SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026